Immediate Impact
1 from Science/Nature 55 standout
Citing Papers
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
2021 Standout
Cardiovascular Disease in Chronic Kidney Disease
2021 Standout
Works of A Moynot being referenced
Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes.
1995
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| A Moynot | 69 | 48 | 107 | 183 | 124 | 11 | 542 | |
| Eileen W. Tsai | 73 | 18 | 50 | 124 | 124 | 16 | 621 | |
| Wu-Hao Tu | 21 | 33 | 56 | 223 | 87 | 16 | 624 | |
| J. Douglas Briggs | 77 | 7 | 45 | 160 | 79 | 14 | 640 | |
| Birgitta Kranz | 65 | 36 | 64 | 301 | 34 | 22 | 597 | |
| Sean O’Regan | 124 | 64 | 74 | 126 | 75 | 27 | 642 | |
| Vincenzo Bisesti | 13 | 61 | 71 | 238 | 82 | 14 | 483 | |
| Teemu Honkanen | 10 | 23 | 94 | 183 | 268 | 18 | 613 | |
| M Schlesinger | 36 | 70 | 95 | 48 | 85 | 24 | 590 | |
| Antonella Bottelli | 12 | 12 | 83 | 170 | 80 | 11 | 531 | |
| Eleonora G. Galvanek | 19 | 45 | 22 | 140 | 51 | 16 | 473 |
All Works
Loading papers...